COMPARATIVE STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Radiographic pneumonia in young, highly febrile children with leukocytosis before and after universal conjugate pneumococcal vaccination.

OBJECTIVES: Studies before the introduction of conjugate pneumococcal vaccine demonstrated a high rate of radiographic pneumonia among highly febrile young children with leukocytosis and no other identified source of infection. We sought to evaluate the impact of universal vaccination with Prevnar (pneumococcal conjugate vaccine [PCV]) on the incidence and characteristics of occult and nonoccult radiographic pneumonia among these children.

METHODS: Retrospective cohort study of children younger than 5 years seen in an urban pediatric emergency department with temperature 39 degrees C or higher, white blood cell count 20,000/microL or higher, and chest radiograph performed. Pneumonia was defined as focal infiltrate or consolidation on chest radiograph as read by an attending radiologist. Occult pneumonia was defined as radiographic pneumonia in the absence of lower respiratory tract signs or cough.

RESULTS: Before universal pneumococcal vaccination, radiographic pneumonia was found in 190 (21%) of 889 (95% confidence interval [CI], 19-24) eligible children compared with 61 (18%) of 335 (95% CI: 14, 23) eligible children after universal vaccination (P = 0.27). Occult pneumonia was identified in 61 (15%) of 404 (95% CI, 12-19) pre-PCV compared with 13 (9%) of 147 (95% CI, 5-15) post-PCV (P = 0.07). In children younger than 2 years, radiographic pneumonia was identified in 121 (17%) of 709 (95% CI, 14-20) pre-PCV and 26 (10%) of 254 (95% CI, 7-15) post-PCV (P = 0.01).

CONCLUSIONS: Clinicians should continue to consider chest radiography in young highly febrile children with leukocytosis and no other identified source of infection.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app